+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | CMV gB C194 Strain |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB |
Host | E. coli |
Conjugation | Unconjugated |
Form | Liquid |
Purity | > 95% (10% PAGE with Coomassie staining) |
Purification | Purified by GS-4B Sepharose Affinity Purification. |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
Molecular Weight | 32 kDa |
Sequence Fragment | Contains the CMV gB immunodominant region. |
Sequence | The exact sequence is proprietary. |
Tag | Contains a GST fusion partner. |
Buffer | 50 mM Tris-HCl, 1 mM EDTA, pH 7.2 containing 50% Glycerol. |
Specificity | Immunoreactive with CMV positive sera. |
Concentration | 1 mg/ml |
Availability | Shipped within 10-20 working days. |
Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |